Assessment and Treatment of Patients With Type 2 Myocardial Infarction and Acute Nonischemic Myocardial Injury.

DeFilippis AP, Chapman AR, Mills NL, de Lemos JA, Arbab-Zadeh A, Newby LK, Morrow DA. · 2019

Read Assessment and Treatment of Patients With Type 2 Myocardial Infarction and Acute Nonischemic Myocardial Injury. by DeFilippis AP, Chapman AR, Mills NL, de Lemos JA, Arbab-Zadeh A, Newby LK, Morrow DA. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6855329.txt.

Introduction

DeFilippis and co-authors clarify a confusing corner of heart care, in Circulation. A heart attack means heart muscle died from lack of oxygen. The classic cause is a clot over a torn plaque. Type 2 infarction is different: supply and demand fall out of balance for other reasons, such as very low blood pressure or fast heart rhythms. Muscle can also be injured with no oxygen shortage at all.

Each year more than 8 million Americans reach hospital with possible heart attack signs, and about 700,000 receive that diagnosis. The authors set out how to tell these groups apart with blood tests and imaging. Treatment differs sharply by cause, so the sorting matters.

Catalog record

CREATORDeFilippis AP, Chapman AR, Mills NL, de Lemos JA, Arbab-Zadeh A, Newby LK, Morrow DA.
YEAR2019
COLLECTIONPAPERS
FORMATTXT
FILE SIZE86 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC6855329

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Assessment and Treatment of Patients With Type 2 Myocardial Infarction and Acute Nonischemic Myocardial Injury By Andrew P DeFilippis, Andrew R Chapman, Nicholas L Mills, James A de Lemos, Armin Arbab-Zadeh, L Kristin Newby, David A Morrow Published in: Circulation DOI: 10.1161/CIRCULATIONAHA.119.040631 ABSTRACT Supplemental Digital Content is available in the text. Keywords: heart injuries, myocardial infarction, myocardial ischemia Myocardial infarction (MI) is defined pathologically as myocardial cell death attributable to prolonged myocardial ischemia (inadequate oxygen supply to the myocardium). Each year, >8 million Americans present to the hospital with signs and symptoms suggestive of acute MI.1 Approximately 700 000 are ultimately diagnosed with MI.1,2 Although coronary thrombus overlying a disrupted atherosclerotic plaque remains the hallmark and primary therapeutic target for MI, multiple other mechanisms are now known to contribute to MI and nonischemic causes of myocardial injury (Table 1, Table I in the online-only Data Supplement, Figure 1); however, optimal diagnostic and treatment strategies for patients with myocardial injury attributable to these nonthrombotic mechanisms have yet to be defined.3,4 [Table: Abbreviated Classification of Myocardial Injury (Definitions Derived From the Fourth Universal Definition of Acute Myocardial Infarction4)] [Figure: Myocardial injury taxonomy.] Over the past decade, cardiac troponin (cTn) assays have become increasingly sensitive, identifying a rising number of patients with previously unrecognized myocardial injury.5,6 Although cTn is highly specific for myocardial injury, it does not differentiate between the etiologically diverse types of MI or non-MI causes of myocardial injury, which may necessitate different treatment strategies.3,4 The Fourth Universal Definition of MI (UDMI) recognizes 5 types of MI and acute and chronic nonischemic myocardial injury as distinct clinical entities (Table 1, Table I in the online-only Data Supplement, Figure 1).4 However, the optimal approach to classify patients with acute myocardial injury into these etiological categories remains uncertain. Clinically actionable diagnosis of acute MI subtypes and nonischemic myocardial injury is essential to foster optimal treatment and outcomes for these patients. Herein, we review evidence regarding the prevalence and outcome of patients classified according to the UDMI, and propose a practical approach to the assessment and management of patients presenting with myocardial injury, with a focus on type 2 MI and nonischemic myocardial injury. UNIVERSAL DEFINITION OF MI In 2007, a consortium, including the European Society of Cardiology, the American College of Cardiology Foundation, the American Heart Association, and the World Heart Federation, aimed to bring consensus to the diagnosis of MI, and proposed a classification system based on etiology. Advances in both diagnostic tools and understanding of the many underlying mechanisms of myocardial injury prompted subsequent revisions that have culminated in the Fourth UDMI.4 The UDMI defines myocardial injury based on the elevation of cTn concentration, with at least one value >99th percentile upper reference limit derived from a normal reference population. Myocardial injury is a broad diagnostic category, under which multiple possible mechanisms are considered (Figure 1). Myocardial injury may be acute, manifested as dynamic changes in cTn concentration over serial measurements, or chronic, in which concentrations are stable or change minimally over serial measurement (Figure 1). Among patients with acute myocardial injury in whom there are symptoms of myocardial ischemia, signs of ischemia on the ECG (ST-segment changes or the development of pathological Q waves), or evidence of a new regional wall motion abnormality, the diagnosis of acute MI is applied. MI is further subclassified by suspected pathophysiology. Type 1 MI is a primary coronary arterial event attributable to atherothrombotic plaque rupture or erosion. Type 2 MI occurs secondary to an acute imbalance in myocardial oxygen supply and demand without atherothrombosis. This imbalance may be attributable to reduced myocardial perfusion in the context of fixed coronary atherosclerosis (without plaque disruption), coronary artery spasm, microvascular dysfunction, coronary embolism, dissection, or systemic causes such as hypoxemia, anemia, hypotension, or bradyarrhythmia, or increased myocardial oxygen demand attributable to tachyarrhythmia or severe hypertension. The UDMI also identifies MI types 3 to 5 in the setting of sudden cardiac death without circulating biomarker evaluation or related to revascularization procedures. Although important, these classifications are not the focus of this article (Table I in the online-only Data Supplement). MI with no obstructive coronary atherosclerosis is a classification independent from the UDMI and includes patients with type 1 and type 2 MI.7 We will refer to acute myocardial injury in the absence of MI as acute nonischemic myocardial injury throughout this article. Persistently elevated cTn levels that do not demonstrate a dynamic rising and/or falling pattern as seen in acute MI or acute nonischemic myocardial injury are categorized as chronic myocardial injury. Both structural cardiac abnormalities (eg, left ventricular hypertrophy, left ventricular dysfunction) and noncardiac conditions (eg, diabetes mellitus, chronic kidney disease) may contribute to chronic myocardial injury.8 Although chronic myocardial injury is important, this article is focused on acute MI and acute nonischemic myocardial injury (Table 1). PREVALENCE OF TYPE 2 MI AND NONISCHEMIC MYOCARDIAL INJURY Among studies using the 2007 and 2012 UDMI, the reported prevalence of type 2 MI ranged from 2% to 58% of patients with MI (Table 2). Variation in type 2 MI prevalence was also observed between sites in the same study (0%–13%).27 This remarkable variation is likely influenced by differences in the patient populations studied, the sensitivity and diagnostic thresholds of the cTn assays used, the rate and types of additional cardiac investigation performed, and limitations of diagnostic criteria and the interpretation of these criteria by adjudicators of MI subtypes (Table 2). For example, the prevalence of type 2 MI among patients presenting to an emergency department for evaluation of suspected MI has ranged from 26% to 58%9–13 versus only 3% to 7% of MIs among patients admitted to an intensive care unit or enrolled in a clinical trial for acute MI.27,28 The proportion of cTn elevations that are adjudicated as acute nonischemic myocardial injury varies substantially by the population studied and has been reported to be greater than the proportion of cTn elevations that are adjudicated as MI (any type; Table 2). [Table: Prevalence and Mortality Associated With Type 1 MI, Type 2 MI, and Myocardial Injury] Type 2 MI may arise in the context of various acute medical and surgical conditions that are similarly associated with nonischemic myocardial injury, making the differentiation between type 2 MI and acute nonischemic myocardial injury challenging in common clinical settings.4,24 Some investigators have simply reported the prevalence and prognosis of all patients with any evidence of myocardial injury that is not attributable to plaque rupture and coronary thrombosis.30,31 Wong and colleagues30 evaluated 1021 consecutive patients admitted to an urban hospital who had ≥1 measurements of cTn. Thirty-one percent had an elevated cTn value, 62% of which were adjudicated as secondary to a cause other than an acute coronary syndrome (ie, type 1 MI). Differentiating myocardial injury subtypes is challenging. In a study of cases that were previously classified as acute MI at 8 Swedish hospitals in 2011, the κ-statistic for agreement on the diagnosis of type 1 MI, type 2 MI, MI types 3 to 5, multifactorial, and nonischemic was poor (κ=0.55).32 However, this study only included cases diagnosed as an acute MI by the treating physician; therefore, it is not representative of the general pool of patients with myocardial injury. In fact,

Read the complete text